Michael Briggs
Chief Scientific Officer at PacCur Inc | Shrewsbury, Massachusetts, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Michael Roy Briggs currently serves as the Chief Scientific Officer at PacCur Inc., where he leverages his extensive expertise in translational medicine, oncology, and metabolic disease research to drive innovative therapeutic development. In his role, Michael oversees the company's scientific strategy, focusing on the integration of cutting-edge preclinical models and assay development to accelerate the translation of novel compounds from bench to bedside. His leadership is instrumental in guiding early-stage drug discovery efforts, optimizing pharmacokinetic and pharmacodynamic profiling, and ensuring the robustness of preclinical efficacy studies.
At PacCur Inc., Michael has spearheaded key projects aimed at developing targeted therapies for difficult-to-treat cancers, including pancreatic and other solid tumors. His deep understanding of protein chemistry, molecular biology, and genetics enables him to design and implement sophisticated in vitro and in vivo models that accurately predict clinical outcomes. Additionally, Michael's expertise in DMPK (Drug Metabolism and Pharmacokinetics) and biomarker development has been vital in establishing translational endpoints that inform clinical decision-making.
Prior to his current role, Michael served as President and CSO at Woodland Biosciences, where he led preclinical research initiatives in oncology and metabolic diseases, further honing his skills in assay development, clinical research, and biopharmaceuticals. His previous tenure at Vertex as Sr. Director and Sector Head of Biology provided him with a strong foundation in discovery biology, especially within the oncology sector focused on pancreatic cancer. Throughout his career, Michael has demonstrated a commitment to advancing translational medicine, fostering collaborations across disciplines, and applying his expertise in protein chemistry, cell-based assays, and drug design to bring innovative therapies closer to clinical realization.
Chief Scientific Officer at PacCur Inc in June 2020 to Present
Chief Scientific Officer at TaxolCur LLC in January 2021 to Present
Adjunct Professor at Tufts Cummings School of Veterinary Medicine in January 2018 to December 2021
President & CSO Woodland Biosciences at Woodland Biosciences in January 2013 to December 2021
President & CSO at Woodland Pharmaceuticals, LLC DBA "Woodland Biosciences" in June 2005 to December 2021
Consultant at Blend Therapeutics, Inc. in January 2012 to June 2012
Sr. Director, Biology at Vertex Pharmaceuticals, Inc. in July 2003 to November 2011
Director at Pfizer in January 2002 to January 2003
Director at Pfizer in January 2000 to January 2003
Assoc. Director at SmithKline Beecham in January 1998 to January 2000
Assoc. Dir. at Ligand Pharmaceuticals, Inc. in August 1993 to December 1998
Lab technician at DuPont in January 1969 to January 1973
See more
See less
University of California, Berkeley, Doctor of Philosophy (Ph.D.), October 1983 to October 1987
University to Texas Southwestern Medical Center, Postdoctoral Fellow, October 1988 to October 2026
UT Southwestern Medical Center, Postdoctoral Fellow, October 1988 to October 1993
University of Zurich, EMBO Fellow, October 1987 to October 1988
University of California, Berkeley, Ph.D., October 1983 to October 1987
University of Delaware, BA, October 1979 to October 1983
The University of Texas Southwestern Medical School, Postdoctoral Fellowship, October 1988 to October 1993
See more
See less
C Level Management
Target Animal Safety
Drug Discovery
Biotechnology
Oncology
In Vivo
In Vitro
Pharmaceutical Industry
Cell
Clinical Development
Pharmacology
Biochemistry
Infectious Diseases
Drug Development
Biomarkers
Cell Biology
Biopharmaceuticals
Translational Medicine
Molecular Biology
CRO
Cancer
Genomics
Technology Transfer
Assay Development
Cell Culture
Lifesciences
Purification
Pharmacokinetics
Validation
Science
Immunology
Antibodies
Systems Biology
Clinical Research
ELISA
Virology
Biomarker Discovery
Protein Chemistry
FDA
High Throughput Screening
Inflammation
Diabetes
HPLC
Drug Design
DMPK
Genetics
Toxicology
Neuroscience
Pharmaceuticals
Cell Based Assays
Drug Delivery
Animal Models
See more
See less
Discover more about PacCur IncWhat is Michael Roy Briggs email address?
Email Michael Roy Briggs at [email protected], [email protected], [email protected] and [email protected]. This email is the most updated Michael Roy Briggs's email found in 2026.
What is Michael Roy Briggs phone number?
Michael Roy Briggs phone number is +16174162522, 5082454360 and 5083204420.
How to contact Michael Roy Briggs?
To contact Michael Roy Briggs send an email to [email protected], [email protected], [email protected] or [email protected]. If you want to call Michael Roy Briggs try calling on +16174162522, 5082454360 and 5083204420. (updated on April 29, 2025)
What company does Michael Briggs work for?
Michael Briggs works for PacCur Inc
What is Michael Briggs's role at PacCur Inc?
Michael Briggs is Chief Scientific Officer
What industry does Michael Briggs work in?
Michael Briggs works in the Pharmaceuticals industry.
Michael Briggs Email Addresses
Michael Briggs Phone Numbers
Get a free list of similar prospects, filtered by title, company, or industry.
Build your Prospect ListPeople like Michael Briggs
Consultant, Business Process Management at Travelers
Partner at Kozad Properties, Ltd.
Financial Advisor at First Command Financial Services, Inc.